ப்ரெவெந்ஶந் ஆய்வுகள் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from ப்ரெவெந்ஶந் ஆய்வுகள். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In ப்ரெவெந்ஶந் ஆய்வுகள் Today - Breaking & Trending Today

At-risk people know PrEP prevents HIV but few take it


For the study in the journal
AIDS and Behavior, researchers surveyed 202 young sexual minority men and transgender women two high-priority populations for HIV prevention to better understand why some were more likely than others to take PrEP.
According to the Centers for Disease Control and Prevention, sexual minority men are the community most affected by HIV, making up 69% of all new diagnoses in 2018, and transgender populations are disproportionately affected by HIV and prevention challenges.
While Black and Hispanic/Latinx populations are mostly likely to be newly diagnosed with HIV, PrEP users are more likely to be white.
The researchers, who are part of the Rutgers School of Public Health’s Center for Health, Identity, Behavior, and Prevention Studies (CHIBPS), found that while 98% of the study’s participants were aware of PrEP, less than 25% were currently taking it. ....

Perryn Halkitis , Caleb Loschiavo , Centers For Disease , Yale University School Of Public Health , University Of Alabama , Rutgers School Of Public Health , Rutgers School Of Public Health Center , Disease Control , Rutgers School , Public Health , Prevention Studies , Yale University School , மையங்கள் க்கு நோய் , யேல் பல்கலைக்கழகம் பள்ளி ஆஃப் பொது ஆரோக்கியம் , பல்கலைக்கழகம் ஆஃப் அலபாமா , ரட்ஜர்ஸ் பள்ளி ஆஃப் பொது ஆரோக்கியம் , ரட்ஜர்ஸ் பள்ளி ஆஃப் பொது ஆரோக்கியம் மையம் , நோய் கட்டுப்பாடு , ரட்ஜர்ஸ் பள்ளி , பொது ஆரோக்கியம் , ப்ரெவெந்ஶந் ஆய்வுகள் , யேல் பல்கலைக்கழகம் பள்ளி ,

Patients with high HIV risk are aware of preventative pill, but few are using it


Patients with high HIV risk are aware of preventative pill, but few are using it
Cisgender sexual minority men and transgender women are aware of pre-exposure prophylaxis (PrEP), a daily pill for HIV-negative people to prevent HIV infection, but few are currently taking it, according to researchers at Rutgers.
The study, published in the journal
AIDS and Behavior, surveyed 202 young sexual minority men and transgender women - two high-priority populations for HIV prevention - to better understand why some were more likely than others to be taking PrEP.
According to the Centers for Disease Control and Prevention, sexual minority men are the community most impacted by HIV, making up 69 percent of all new diagnoses in 2018, and transgender populations are disproportionately affected by HIV and prevention challenges. While Black and Hispanic/Latinx populations are mostly likely to be newly diagnosed with HIV, PrEP users are more likely to be white. ....

Perryn Halkitis , Emily Henderson , Caleb Loschiavo , Centers For Disease , Rutgers University , Study Co , School Of Public Health , Rutgers School Of Public Health Center , Rutgers School Of Public Health , Disease Control , Rutgers School , Public Health , Prevention Studies , Study Co Author , Doctoral Candidate , எமிலி ஹென்டர்சன் , மையங்கள் க்கு நோய் , ரட்ஜர்ஸ் பல்கலைக்கழகம் , படிப்பு இணை , பள்ளி ஆஃப் பொது ஆரோக்கியம் , ரட்ஜர்ஸ் பள்ளி ஆஃப் பொது ஆரோக்கியம் மையம் , ரட்ஜர்ஸ் பள்ளி ஆஃப் பொது ஆரோக்கியம் , நோய் கட்டுப்பாடு , ரட்ஜர்ஸ் பள்ளி , பொது ஆரோக்கியம் , ப்ரெவெந்ஶந் ஆய்வுகள் ,